Faruqi & Faruqi, LLP, As Co-Lead Counsel, Secures Revival Of Synergy Pharmaceuticals Investors’ Suit At Second Circuit

Katherine M. Lenahan Katherine M. Lenahan Katherine M. Lenahan

Tel: (212) 983-9330
Fax: (212) 983-9331
E-mail: klenahan@faruqilaw.com

On Monday, August 28, 2023, the Second Circuit Court of Appeals revived certain securities fraud claims previously dismissed in In re Synergy Pharmaceuticals, Inc. Sec. Litig., No. 18-cv-873, 2021 WL 4480625 (E.D.N.Y. Sept. 30, 2021).  In a Summary Order, the Second Circuit panel found that investors in bankrupt drugmaker, Synergy Pharmaceuticals, Inc., adequately alleged that a statement regarding Synergy’s access to non-dilutive capital was made with the requisite level of intent.  The district court’s judgment was vacated in part and the case was remanded back to the district court for further proceedings consistent with the Second Circuit’s order.

The investors are represented by Faruqi & Faruqi, LLP, as co-lead counsel.  A copy of the Second Circuit’s order is linked below.

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885


3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania